Skip to main content

Subcutaneous Drug Development & Delivery Consortium Inc

Beaverton, Oregon·EIN 85-0837695·NTEE S46 · Community Improvement & Capacity Building·501(c)(6)·Filing year 2024
Total revenue
$720k
Total assets
$1.2M
Total expenses
$492k
Reported officers
4

How Subcutaneous Drug Development & Delivery Consortium Inc’s pay compares

Its latest Form 990 lists no roles we can compare, so there is no comparison for it yet.

Chief Executive Officer pay at Community Improvement & Capacity Building organizations of similar size in Oregon

25th
$70k
Median
$91k
75th
$136k

From the Form 990 filings of 20 Community Improvement & Capacity Building organizations of similar size in Oregon.

See Chief Executive Officer pay in full

OUR MISSION IS TO COLLABORATIVELY ADVANCE THE MOST PRESSING ISSUES AND OPPORTUNITIES IN SUBCUTANEOUS DOSAGE AND DELIVERY IN A PRECOMPETITIVE MANNER.

Reported officers (all unpaid)

No paid executives reported in 2024. Subcutaneous Drug Development & Delivery Consortium Inc reported 4 unpaid officers and board members on its 990.

President
Vice Preside
Director
Treasurer

Revenue and expenses over time

Subcutaneous Drug Development & Delivery Consortium Inc reported revenue and expenses across 2 filing years.

RevenueExpenses
$760k
$769k
2023
$720k
$492k
2024
Total revenue and total expenses from IRS Form 990 filings.

What the Chief Executive Officer earns at organizations like this one

Subcutaneous Drug Development & Delivery Consortium Inc reported no executive compensation in its latest filing. For context, the Chief Executive Officer at Community Improvement & Capacity Building organizations of similar size in Oregon earns a median of $90,678.

25th percentile
$70k
Median
$90,678
75th percentile
$136k
90th percentile
$162k

These are pay figures for organizations like this one, not this organization's reported pay. Based on 20 organizations.

See full Community Improvement & Capacity Building compensation data →

Common questions about Subcutaneous Drug Development & Delivery Consortium Inc

What are Subcutaneous Drug Development & Delivery Consortium Inc's revenue and expenses?

In 2024, Subcutaneous Drug Development & Delivery Consortium Inc reported $720k in total revenue and $492k in total expenses on its IRS Form 990.